Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case‐control study in nonsmoking postmenopausal women from the EPIC cohort

• Published in: International journal of cancer 2016-03, Vol.138 (5), p.1129-1138
• Main Authors: Obón‐Santacana, Mireia, Freisling, Heinz, Peeters, Petra H., Lujan‐Barroso, Leila, Ferrari, Pietro, Boutron‐Ruault, Marie‐Christine, Mesrine, Sylvie, Baglietto, Laura, Turzanski‐Fortner, Renee, Katzke, Verena A., Boeing, Heiner, Quirós, J. Ramón, Molina‐Portillo, Elena, Larrañaga, Nerea, Chirlaque, María‐Dolores, Barricarte, Aurelio, Khaw, Kay‐Tee, Wareham, Nick, Travis, Ruth C., Merritt, Melissa A., Gunter, Marc J., Trichopoulou, Antonia, Lagiou, Pagona, Naska, Androniki, Palli, Domenico, Sieri, Sabina, Tumino, Rosario, Fiano, Valentina, Galassom, Rocco, Bueno‐de‐Mesquita, H. B(as), Onland‐Moret, N. Charlotte, Idahl, Annika, Lundin, Eva, Weiderpass, Elisabete, Vesper, Hubert, Riboli, Elio, Duell, Eric J.
• Format: Article
• Language: English
• Subjects: Acrylamide; Acrylamide - metabolism; Adducts; Alcohols; Bioindicators; Biomarkers - blood; Blood cells; Body mass; Cancer; Carbohydrates; Carcinogens; Case-Control Studies; Dietary intake; Endometrial cancer; Endometrial Neoplasms - etiology; Endometrium; EPIC; Epoxy Compounds - metabolism; Erythrocytes; Exposure; Female; Food; glycidamide; Health risk assessment; Health risks; Heat treatment; Hemoglobin; hemoglobin adduct; Hemoglobins - metabolism; High-performance liquid chromatography; Hormone replacement therapy; Humans; Liquid chromatography; Medical research; Medicin och hälsovetenskap; Middle Aged; Oral cavity; Post-menopause; Postmenopause; Prospective Studies; Regression analysis; Risk; Smoking; Tempering
• ISSN: 0020-7136; 1097-0215; 1097-0215
• DOI: 10.1002/ijc.29853

Acrylamide, classified in 1994 by IARC as “probably carcinogenic to humans,” was discovered in 2002 in some heat‐treated, carbohydrate‐rich foods. Four prospective studies have evaluated the association between dietary acrylamide intake and endometrial cancer (EC) risk with inconsistent results. The purpose of this nested case‐control study, based on the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, was to evaluate, for the first time, the association between hemoglobin adducts of acrylamide (HbAA) and glycidamide (HbGA) and the risk of developing EC in non‐smoking postmenopausal women. Hemoglobin adducts were measured in red blood cells by HPLC/MS/MS. Four exposure variables were evaluated: HbAA, HbGA, their sum (HbAA+HbGA), and their ratio (HbGA/HbAA). The association between hemoglobin adducts and EC was evaluated using unconditional multivariable logistic regression models, and included 383 EC cases (171 were type‐I EC), and 385 controls. Exposure variables were analyzed in quintiles based on control distributions. None of the biomarker variables had an effect on overall EC (HRHbAA;Q5vsQ1: 0.84, 95%CI: 0.49–1.48; HRHbGA;Q5vsQ1: 0.94, 95%CI: 0.54–1.63) or type‐I EC risk. Additionally, none of the subgroups investigated (BMI